Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationDiana Ferraro, Carlo Pozzilli, Mauro Zaffaroni et al.|Journal of Neurology|2021Cited by 10
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Viola Baione, Irene Schiavetti et al.|Multiple Sclerosis and Related Disorders|2022Cited by 10
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Luisa Imberti, Virginia Quaresima et al.|Journal of Neuroimmunology|2023Cited by 1